LUMO - Lumos Pharma GAAP EPS of -$3.65 beats by $0.24 revenue of $0.23M beats by $0.22M March, 10 2022 04:02 PM Lumos Pharma Inc. Lumos Pharma press release (NASDAQ:LUMO): FY GAAP EPS of -$3.65 beats by $0.24. Revenue of $0.23M (+35.3% Y/Y) beats by $0.22M. For further details see: Lumos Pharma GAAP EPS of -$3.65 beats by $0.24, revenue of $0.23M beats by $0.22M